patient-derived xenograft

October 3, 2017October 3, 2017

Champions Oncology Awarded $2 Million NCI Grant to Develop, Study Prostate Cancer Models

News

Champions Oncology has signed a $2 million competitive contract through the National Cancer Institute’s (NCI) Small Business Innovation Research (SBIR) program to build and study metastatic prostate cancer models derived ... Read more

February 20, 2017

Champions Oncology Says New Xenograft Models Will Aid Prostate Cancer Research

News

Champions Oncology has added new cohorts of patient-derived xenograft (PDX) models to its TumorBank, expanding the company’s product line in castrate-resistant prostate cancer (CRPC) and other ailments. The new PDX models ... Read more